Kidney Drug Plan Divides Transplant And Dialysis Supporters

email to a friend

printer friendly

opinions

Current Article Ratings:

Patient / Public:		5 (1 votes)
Healthcare Prof:		5 (1 votes)

The New York Times: "A Congressional proposal to help pay for drugs needed by transplant recipients to prevent rejection of donated kidneys has run into opposition from dialysis providers, drug companies and the National Kidney Foundation." The groups support extending Medicare drug coverage but say the measure would cut funding for dialysis. "The proposal has created a rift between those in the business of providing dialysis and those in the business of performing transplants. The discord is being felt on Capitol Hill, and supporters of the measure fear it may make it easy for Congress to kill the provision altogether in the late stages of negotiation." Meanwhile, the House health overhaul bill "includes a provision that would provide Medicare coverage for immunosuppressant drugs for all beneficiaries for life, starting in 2012." But the issue is currently not addressed in the Senate health bill, though "the second-ranking Democrat in the Senate, Richard J. Durbin of Illinois, last week submitted an amendment that replicates the House language, giving the provision a badly needed lift" (Sack, 12/14).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

• Additional
• References
• Citations